DR — Medical Facilities Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$252.38m
- CA$477.01m
- $445.58m
- 92
- 90
- 93
- 100
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 25.4 | 35.7 | 46.5 | 12.3 | 44 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 30.6 | 32.2 | 29.3 | 38.2 | 22.7 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -13.7 | -8.66 | -26.9 | -14.3 | -15.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 77.1 | 87.1 | 75.6 | 57 | 72.7 |
Capital Expenditures | -12.6 | -7.52 | -8.42 | -6.72 | -16.1 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 13.9 | 25.8 | -0.267 | 0.943 | 2.39 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 1.37 | 18.3 | -8.69 | -5.78 | -13.7 |
Financing Cash Flow Items | -29.5 | -25.6 | -32.9 | -26.5 | -27.5 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -83.7 | -71.2 | -72.1 | -77.4 | -69.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.7 | 34.2 | -5.14 | -26.1 | -10.8 |